Market Size of Swine Healthcare Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 3.30 Billion |
Market Size (2029) | USD 4.54 Billion |
CAGR (2024 - 2029) | 6.59 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Swine Healthcare Market Analysis
The Swine Healthcare Market size is estimated at USD 3.30 billion in 2024, and is expected to reach USD 4.54 billion by 2029, growing at a CAGR of 6.59% during the forecast period (2024-2029).
The COVID-19 pandemic led to disruptions in not only the R&D activities of other therapies and drugs for medical conditions other than COVID-19 but also impacted the veterinary industry, as the logistics supply of various essential veterinary pharmaceutical products was adversely impacted. For instance, according to the research study published by Anna K. Johnson in the December 2021 issue of the National Library of Medicine, due to the COVID-19 pandemic, supply chain disruptions in Lowa, United States, caused producer uncertainty, confusion, and stress, including time-sensitive challenges for maintaining animal care. To overcome these challenges, the Lowa Resource Coordination Center (IRCC) was created to support swine welfare. Therefore, COVID-19 had an unprecedented impact on the swine healthcare market in its initial phase; however, with the slowing down of infections and large-scale vaccinations, the studied market is expected to reach the potential of the pre-COVID era. For instance, in January 2022, an article published by William Reed stated that pig feed production in 2021 increased by 6.5% due to growth in the Asia-Pacific region. Thus, with such increased growth, the market is expected to grow over the forecast period.
The major factor driving the growth of the swine healthcare market is the rising incidence of swine diseases around the world, which is expected to drive the demand for swine healthcare products for diagnostics and treatment. For instance, according to the March 2022 update of the FAO of the United Nations, African swine fever (ASF) has been reported in the administrative areas of the following countries, namely, China, Mongolia, Vietnam, Cambodia, the Democratic People's Republic of Korea, Myanmar, the Philippines, Indonesia, India, Malaysia, and others, which shows a high prevalence of ASF in different countries of the world. Thus, the demand for diagnostics and treatment products for ASF is expected to increase, which is expected to fuel the growth of the studied market.
As per the research study published in September 2021 by Yin Li and Ian Robertson, swine influenza is a major health concern for the swine industry, as swine influenza can not only cause large economic losses for the pig industry but can also lead to epidemics or pandemics in the human population, and it is one of the most ubiquitous diseases circulating in the global pig population. As per the same source, the major diagnostic techniques used for detecting swine influenza include serological methods (e.g., hemagglutination inhibition (HI) test and enzyme-linked immunosorbent assay (ELISA)), molecular methods (e.g., polymerase chain reaction (PCR)), and virus isolation methods. Hence, with the growing burden of these diseases and awareness about them, the demand for swine healthcare products is anticipated to increase over the forecast period.
Moreover, the increasing demand for livestock products, along with increasing R&D investment in the area of novel therapeutics, is expected to augment the growth of the swine healthcare market. For instance, in September 2021, the United States Department of Agriculture pledged up to USD 500 million from the Commodity Credit Corporation to prevent African swine fever. The amount will be spent on expansion, coordination, monitoring, and surveillance of the disease, along with other efforts. However, the stringent regulatory policies and high cost of swine healthcare products are expected to impede the growth of the swine healthcare market during the forecast period.
Swine Healthcare Industry Segmentation
As per the scope of the report, pig production is an important component of global food security, agricultural economies, and local and international trade, and swine health is associated with various diseases associated with pigs. The development of diagnostics and therapeutics products to prevent related ailments and disorders affects the stability and productivity of the global swine industry. The Swine Healthcare Market is Segmented by Products (Diagnostics Tests (Enzyme-Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging, and Other Diagnostics) and Therapeutics (Vaccines, Parasiticides, Anti-infectives, Feed additives, and Other Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Other Diseases), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.
By Product | ||||||||
| ||||||||
|
By Disease | |
Exudative dermatitis (greasy pig disease) | |
Coccidiosis | |
Respiratory diseases | |
Swine dysentery | |
Porcine parvovirus | |
Other Diseases |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Swine Healthcare Market Size Summary
The swine healthcare market is poised for significant growth, driven by the increasing incidence of swine diseases globally and the rising demand for livestock products. The market is recovering from the disruptions caused by the COVID-19 pandemic, which affected supply chains and logistics in the veterinary industry. As the pandemic's impact wanes, the market is expected to regain its pre-COVID momentum. The prevalence of diseases such as African swine fever and swine influenza is fueling the demand for diagnostic and treatment products, thereby propelling market expansion. Additionally, advancements in vaccine development, including genetically engineered components, are expected to enhance immunity in pigs and drive the vaccine segment's growth. The market is characterized by substantial investments from key companies and research institutions in the development and launch of new vaccines, which are anticipated to increase competition and market share.
North America is projected to dominate the swine healthcare market, supported by a well-established swine industry and a high incidence of swine infections. The United States, in particular, is expected to hold a significant market share due to increased investments in research and development, as well as the approval of new drugs and vaccines. Initiatives such as grants and regulatory approvals are expected to further stimulate market growth in the region. The market is moderately competitive, with major players like Zoetis Animal Healthcare, Merck Animal Health, and Elanco actively engaging in strategies such as collaborations, mergers, and product launches to enhance their market presence. Overall, the swine healthcare market is set for robust growth, driven by disease prevalence, technological advancements, and strategic investments.
Swine Healthcare Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Incidence of Swine Diseases
-
1.2.2 Increasing Demand for Livestock Products
-
1.2.3 Increasing Investments in R&D Activities to Develop Novel Therapeutics
-
-
1.3 Market Restraints
-
1.3.1 Stringent Regulatory Framework
-
1.3.2 High Cost Associated with Swine Health Especially in the Developing Countries
-
-
1.4 Porter Five Forces
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Diagnostic Tests
-
2.1.1.1 Enzyme Linked Immuno-Sorbent Assay (ELISA)
-
2.1.1.2 Rapid Immuno Migration (RIM)
-
2.1.1.3 Agar Gel Immuno-Diffusion (AGID)
-
2.1.1.4 Polymerase Chain Reaction (PCR)
-
2.1.1.5 Diagnostic Imaging
-
2.1.1.6 Other Diagnostics
-
-
2.1.2 Therapeutics
-
2.1.2.1 Vaccines
-
2.1.2.2 Parasiticides
-
2.1.2.3 Anti-infectives
-
2.1.2.4 Feed additives
-
2.1.2.5 Other Therapeutics
-
-
-
2.2 By Disease
-
2.2.1 Exudative dermatitis (greasy pig disease)
-
2.2.2 Coccidiosis
-
2.2.3 Respiratory diseases
-
2.2.4 Swine dysentery
-
2.2.5 Porcine parvovirus
-
2.2.6 Other Diseases
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Swine Healthcare Market Size FAQs
How big is the Swine Healthcare Market?
The Swine Healthcare Market size is expected to reach USD 3.30 billion in 2024 and grow at a CAGR of 6.59% to reach USD 4.54 billion by 2029.
What is the current Swine Healthcare Market size?
In 2024, the Swine Healthcare Market size is expected to reach USD 3.30 billion.